Is cabozantinib safe?

Cabozantinib (Cabozantinib), as a targeted therapy, has been proven to have certain efficacy in the treatment of various types of cancer. However, like all drugs, there are certain safety considerations with the use of cabozantinib. During clinical use, cabozantinib may cause a series of adverse reactions, including but not limited to fatigue, nausea, vomiting, diarrhea, hand-foot syndrome, hypertension, headache, joint pain, etc. In addition, cabozantinib may also cause some serious adverse reactions, such as bleeding, heart problems, abnormal liver function, etc., so patients need regular clinical monitoring and evaluation during use. Nonetheless, for most patients, the benefits of cabozantinib generally outweigh its potential risks. Therefore, an adequate risk versus benefit assessment is usually performed before patients and physicians jointly decide to treat with cabozantinib. At the same time, doctors will adjust the dosage and treatment plan according to the patient's specific situation and clinical status to minimize the occurrence of adverse reactions and ensure the safety and effectiveness of the treatment.